ArticleAnnals of neurology2018
Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.
Hayley S McLoughlin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
97 papers cite itlatest 60 shown
this paperpooled itcites it